Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cardiac Risk Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07625553
What this trial is testing

Study of the Relaxin Agonist R2R01 in Patients at High Risk for Cardiac Surgery Associated- Acute Kidney Injury

Who this might be right for
Acute Kidney Injury
River 2 Renal Corp. 430
Testing effectiveness (Phase 2)Study completedNCT05042973
What this trial is testing

The Metabolic Effects of Empagliflozin in Patients With High Risk of Heart Failure

Who this might be right for
ObesityHeart Failure
Jacob Moller 165
Not applicableStudy completedNCT02316054
What this trial is testing

Evaluation of Myocardial Perfusion Heterogeneity Imaging in Diabetes Patients (EVADIAB)

Who this might be right for
Type 2 Diabetes
University Hospital, Grenoble 170
Not applicableStudy completedNCT02834377
What this trial is testing

Personalized Hemodynamic Therapy in Patients Undergoing High-risk Surgery

Who this might be right for
Postoperative Complications
Universitätsklinikum Hamburg-Eppendorf 188
Post-approval studies (Phase 4)Study completedNCT00442325
What this trial is testing

Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets

Who this might be right for
Coronary ArteriosclerosisDiabetes Mellitus, Type 2Cerebrovascular Accident+2 more
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 595
Not applicableStudy completedNCT05448625
What this trial is testing

Genoss DES in Patients With a High Risk of Ischemic Events (GENTLE Registry)

Who this might be right for
Drug-eluting StentCoronary Artery Disease
Yonsei University 200
Not applicableNot Yet RecruitingNCT07598682
What this trial is testing

Trajectory-Based Phenotyping After Coronary Artery Bypass Surgery

Who this might be right for
Coronary Artery Bypass GraftingPostoperative Acute Kidney InjuryPostoperative Complications+1 more
Bursa Sevket Yilmaz Training and Research Hospital 1,000
Not applicableActive Not RecruitingNCT05893420
What this trial is testing

A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning

Who this might be right for
SepsisSepticemiaRespiratory Failure+4 more
AgileMD, Inc. 30,000
Testing effectiveness (Phase 2)Study completedNCT00002624
What this trial is testing

Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 66
Not applicableUnknownNCT00989924
What this trial is testing

Research on the Correlation Among Magnetocardiography Patterns and Known Cardiovascular Risk Factors in Diabetic Patients

Who this might be right for
Diabetes Mellitus
National Taiwan University Hospital 1,100
Not applicableStudy completedNCT04371289
What this trial is testing

Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up

Who this might be right for
COVID-19Cardiovascular Risk Factor
Istituto Auxologico Italiano 4,356
Not applicableUnknownNCT04857268
What this trial is testing

Diagnostic Validation of Wearable ECG Monitoring Patch, ATP-C120

Who this might be right for
Atrial Fibrillation New Onset
Seoul National University Bundang Hospital 320
Post-approval studies (Phase 4)Ended earlyNCT00651378
What this trial is testing

Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)

Who this might be right for
HypercholesterolemiaAtherosclerosisCoronary Artery Disease
Organon and Co 87
Not applicableStudy completedNCT04255043
What this trial is testing

Intravascular Ultrasound Versus Angiography Guided Drug-coated Balloon

Who this might be right for
Coronary Artery Disease
Nanjing First Hospital, Nanjing Medical University 260
Not applicableStudy completedNCT02560168
What this trial is testing

Analysis of Surface EKG Signals to Identify Myocardial Dysfunction in Patients at Risk for Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Icahn School of Medicine at Mount Sinai 200
Not applicableNot Yet RecruitingNCT06532019
What this trial is testing

Clinical Study of Active Intervention in High-risk HFpEF Patients

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Xiangtan Central Hospital 924
Not applicableStudy completedNCT07473063
What this trial is testing

Optimization of Heart Failure Treatment and Implementation of a Risk-based Patient Care Model.

Who this might be right for
Heart Failure
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS 2,428
Not applicableStudy completedNCT03102671
What this trial is testing

Effectiveness of the HeartHab Application on Exercise Capacity in Patients With Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Hasselt University 30
Not applicableEnrolling By InvitationNCT05889416
What this trial is testing

The Perfect-CR Implementation Study

Who this might be right for
Myocardial InfarctionRisk Reduction
Skane University Hospital 75
Not applicableNot Yet RecruitingNCT06821711
What this trial is testing

Optimal LDL-C Target in High-risk Patients After PCI

Who this might be right for
Chronic Coronary SyndromeAcute Coronary SyndromesPercutaneous Coronary Intervention+1 more
Xijing Hospital 12,000
Next Page